DNMT1 is associated with cell cycle and DNA replication gene sets in diffuse large B-cell lymphoma

Area of Science:

• Molecular Biology
• Oncology
• Epigenetics

Background:

• DNA (cytosine-5)-methyltransferase 1 (DNMT1) dysregulation is linked to cancer pathogenesis.
• DNMT1 is frequently expressed in diffuse large B-cell lymphoma (DLBCL), but its role is unclear.
• Understanding DNMT1's function in DLBCL is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the function of DNMT1 in germinal center B-cell-like DLBCL (GCB-DLBCL).
• To determine the correlation between DNMT1 expression and cellular processes in DLBCL.
• To identify key biological pathways regulated by DNMT1 in GCB-DLBCL.

Main Methods:

• Gene expression profiling (GEP) of DNMT1-silenced (shDNMT1) and control DLBCL cell lines (HT).
• Independent gene set enrichment analysis (GSEA) on GEP data and public DLBCL datasets (GSE10846, GSE31312).
• Venn analysis to identify consensus enriched gene sets and correlation analysis between DNMT1 and target genes.

Main Results:

• DNMT1 expression positively correlated with enriched gene sets related to cell cycle progression and DNA replication.
• Genes crucial for cell cycle activation and DNA replication (e.g., CDK1, CCNA2, PCNA) were highly correlated with DNMT1.
• DNMT1 silencing led to significant downregulation of these cell cycle and DNA replication genes in DLBCL cells.

Conclusions:

• DNMT1 plays a significant role in promoting cell cycle activation and DNA replication in DLBCL.
• The findings suggest DNMT1 is a key regulator of proliferation in DLBCL.
• DNMT1 represents a potential therapeutic target for DLBCL treatment.